Market Cap 1.50B
Revenue (ttm) 0.00
Net Income (ttm) -133.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,221,800
Avg Vol 1,820,952
Day's Range N/A - N/A
Shares Out 105.20M
Stochastic %K 62%
Beta 0.36
Analysts Strong Sell
Price Target $40.00

Latest News on EWTX

Analysts Think There's Still Time To Get In On Edgewise

Sep 30, 2024, 12:12 PM EDT - 8 months ago

Analysts Think There's Still Time To Get In On Edgewise


Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge

Sep 25, 2024, 11:50 AM EDT - 9 months ago

Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge


Wedbush's Laura Chico talks biotech investing in 2024

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

IBB NBIX VRDN XBI